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and  mortality  both   in  hospital  and   in   the   community.  The   impact  of 
venous   thromboembolism   on   morbidity   and   mortality   is   largely 
unrecognised   in   daily   practice   because   of   low  autopsy   rates.  Despite 
thromboembolic prophylaxis, symptomatic and asymptomatic pulmonary 
embolism   occurs   in   approximately   25%   of   surgical   patients   and   is 
responsible for 3% of  surgical  inpatient deaths.  Approximately 25% of 
patients who have a fatal pulmonary embolism have had recent surgery. 
An understanding of the underlying epidemiology, pathophysiology and 
natural   history   of   deep   vein   thrombosis   is   essential   in   guiding 
appropriate   prophylaxis,   diagnosis   and   treatment.  Recognition   of   the 
underlying risk factors and an appreciation of the multifactorial nature 
of  deep  vein   thrombosis  may  facilitate   the   identification  of   situations 



















embolism. Tests   for  evaluating the presence of  hypercoagulable states 
were done in a few patients who could afford.
A   structured   proforma   for   clinical   assessment,   diagnosis   and 
management was framed and the data compiled and analysed.
All patients were treated by lower limb elevation, absolute bed rest 
for  one week,   intravenous  bolus  unfractionated heparin   for  one week, 
tablet Acitrom 4 mg once daily to be overlapped with heparin for 5 days 








The   first   report   on   deep   vein   thrombosis   was   published   in   1810,   Ferriar 
described   a   patient   with   phlegmasia   alba   dolens.   In   1859   Virchow   described   his 
revolutionary discovery of the three main causes of deep vein thrombosis.
EPIDEMIOLOGY
Deep   vein   thrombosis   most   often   complicates   the   course   of 
severally  ill,  hospitalised patients but may also affect ambulatory and 












Mechanical   venous   injury   clearly   plays   a   role   in   thrombosis 
associated with direct venous trauma (Dennis JW. 1993) (17). However, 
focal  venous   injury cannot account   for bilateral  venous  thromboses   in 
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77%,   compared   to  unilateral  23%.  Overt   endothelial   injury   is  neither 
necessary   nor   sufficient   to   cause   thrombosis.   The   potential   role   of 
biochemical   injury   to   the  venous   endothelium has  been   explained  by 
Mammen EF (1992) (43). 













Approximately   47%   of   patients   with   a   document   deep   vein 
thrombosis have one or more recognised risk factors with the incidence of 




In   the   Framingham   study,   advanced   age   was   significantly 
associated with  fatal  pulmonary embolism (Goldhaber SZ et  al.  1983) 
(25). In their study of out of hospital patients, Anderson et al. reported 
an association between advancing age and thrombosis.  In virtually all 
studies   recruiting   consecutive   patients   with   documented   venous 
thromboembolism  for  scientific  purpose,  old  patients   formed the  large 
majority of the entire cohort.
PROLONGED IMMOBILISATION
The   association   between   lack   of  mobility   and   venous   thrombosis   has   been 
confirmed   in   a   number   of   autopsy   and   clinical   studies.     The   contribution   of 
immobilisation as an independent risk factor for venous thromboemoblism emerged in a 
study in hemiplegic patients, where the non paralysed leg served as control. Waslow et 
al   (1972)   (62)   found evidence  of  deep vein  thrombosis  using  the radiofibrinogen I125 




deep   vein   thrombosis   and   this   risk   continuous   after   discharge   from 
10
hospital.  Surgery constitutes a spectrum of  risk that  is   influenced by 
patient age, coexistent thrombotic risk factors, type of procedure, extent 
of   surgical   trauma  length  of   procedure  and  duration   of  postoperative 
immobilization.
Clagett  GP   et   al   (1995)   (9)   showed   the   incidence   of   deep   vein 
thrombosis to be 19% after general surgery, 24% following neurosurgery, 
50% for hip and knee arthroplasties. Macklan NS et al (1996) showed 
that   51%   of   gynaecologic   patients   developed   deep   vein   thrombosis 
following   initial   discharge.   Surgery   in   accompanied   by   perioperative 














vein   thrombosis   in   patients  who   died   of   cancer,   particularly   those  with  mucinous 
carcinomas of the pancreas, lung and gastrointestinal tract.
The  conditions   that  make   cancer  patients   susceptible   to   thrombosis  are   the 



















Gertsman  BB   (1991)   (22)   proved   the   dose   response   between   the   content   of 
estrogen and the risk for deep vein thrombosis.





with   a   history   of   venous   thromboembolism   compared   to   those  without   a   previous 
episode.
PRIMARY HYPERCOAGULABLE STATES














to be between 1:16,000 and 1:36,000 and that of  asymptomatic  protein  C deficiency 



























The penetrance  of   thrombosis   in activated protein C resistant  individuals  is 
highly variable.  Some  individuals never  develop thrombosis,  whereas others  develop 
recurrent, severe thrombotic events at a young age.
Activated   protein  C   resistance   (factor   v   Leiden)   in   present   is   3   to   10%   of 
caucasians and virtually absent in other races (Zoller B 1997) (66).
Rees MM et al (1943) (51) elaborated on hyperhomocysteinemia as a result of 
homozygous   cystathionine   ß­synthase   deficiency   and   these   patients   develop 
homocystinuria, premature vascular disease and thrombosis.
ANTIPHOSPHOLIPID ANTIBODY SYNDROME
Antiphospholipid   antibodies   are   a   heterogeneous   group   of   immunoglobulins 
directed against negatively charged phospholipids, protein­phospholipid complexes, or 
plasma   proteins   such   as  β­2   glycoprotein.   Antiphospholipid   antibody   includes 
anticardiolipin and lupus anticoagulant antibodies.
Both lupus anticoagulant and anticardiolipin antibodies are characteristically 
found  in patients with systemic  lupus erythematosus,  but can be observed  in other 
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autoimmune diseases and even in the absence of any underlying disease. The presence 
of   these   antibodies   has   been   associated  with   the   clinical   features   of   the   so­called 


















50   years.   In   most   cases,   patients   develop   deep   vein   thrombosis   and   pulmonary 
embolism, there are also occassional reports of thrombosis in unusual sites and in the 








the  false positive or  false negative diagnoses.  They  found that patients with a high 
clinical   suspicion   of   deep   vein   thrombosis   had   a   85%   chance   and   having   a 
phlebographically proven deep vein thrombosis.
DIAGNOSTIC TECHNIQUES





clinical   one  until   the  1960s,  when   contrast   venography  became a  part   of   standard 
medical   practice.  Lower   extremity   venography  was  used   by  dos  Santas   in   1938   to 
confirm a clinically suspected diagnosis of deep vein thrombosis.
In 1940, Bauer published details  of  normal  venographic anatomy and of  the 
venographic appearance of acute and chronic deep vein thrombosis. Diagnostic criteria 
for deep vein thrombosis were established in 1963 by De Weese and Rogoff. In the past 
decades,   the   technique   used   for   lower   extremity   ascending   venography   has   been 
modified  many   times.   However   even   as   the   technique   has   been   refined   and   the 
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examination has been made safer and less painful with the use of  modern contrast 
agents,   it   remains   a   relatively   invasive   study   that   requires   an   often   painful 
venipuncture,   injection   of   iodine   based   contrast   agents   and   exposure   of   patient   to 
ionising radiation.  Comerota  AJ et  al   (1985)   (13)  showed that  this   test  may not  be 
feasible or is inadequate for interpretation in upto 20% of patients.






venous   capacitance.   The   techniques   strain   gauge   plethysmography,   impedance 






obstruction,   the   peripheral   venous   pressure   is   already   elevated  with   an   increased 
baseline   venous   volume   and  maximal   venous   capacitance   is   reached  with   smaller 
volume changes.








quantify   resolution   of   thrombus   in   patients   whose   abnormal   impedance 













accurate   for   proximal     deep   vein   thrombosis   in   symptomatic   patients.   It   is   least 







Venous   thrombosis   produces   an   inflammatory   reaction   with   release   of 
vasoactive substances, causing a microcirculatory hyperemic response and increase in 
local   skin   temperature   of  up   to   2oC.  This   temperature   change  may  not   be   evident 
clinically,  but it  can be detected with thermographic techniques.  A normal scanning 























colour   flow     instruments.  At   each   site,   venous   compressibility   and   the  presence   of 
echogenic thrombus are evaluated on the B mode image, while Doppler is used to assess 
venous flow characteristics. Venous incompressibility is the most widely used diagnostic 
criterion  for acute deep vein thrombosis.  Other diagnostic  criteria  include thrombus 















for   the   diagnosis   of   proximal   venous   thrombosis   in   comparison   with   ascending 
photography. The true value of  MRV is  likely to be  in the patients with pelvic  and 
venacaval thrombosis for which traditional diagnostic studies are inadequate.
In   a   study   of   101   lower   extremity,   abdominal   and   pelvic   venous   systems, 





Magnetic   resonance   imaging   /     Magnetic   resonance   venography   not   only 
accurately identifies the site of deep vein thrombosis, but also allows the identification 
of conditions that may cause, mimic or be associated with venous thrombosis, such as 
ruptured   Baker’s   cyst,   cellulitis,   muscle   tears,   hematomas   and   external   venous 
compression from tumours or other anatomic anomalies. Magnetic resonance imaging 
and Magnetic resonance venography technology can serve as a useful adjuvant imaging 
modality   that   offers  a  non   invasive   approach   to   the  difficult  diagnostic   problem of 
assessing non­neoplastic  venous thrombosis of  the renal veins.  They can also depict 
normal and abnormal hepatic  and portal  venous anatomy is relation to the hepatic 






Although   D­dimer   levels   are   elevated   in   postoperative   and   acutely   ill   patients, 
(Rowbotham BJ et al 1987), Ginsberg colleagues (23) showed that a normal D­dimer 
value had a negative predictive value of 97%.

















replacement   patients   (Coventry   MB   et   al   1973)   (15)   and   4%   to   7%   in   patients 
undergoing surgery for a fracture hip (Esteland G. et al. 1986).





thrombosis   has   been   established   by  multiple   randomized   clinical   trials.   Low   dose 
subcutaneous heparin in usually given in a dose of 5000 units 2 hours preoperatively 
and postoperatively every 8 or 12 hours. Pooled data from meta­analyses confirm that 
low   dose   heparin   significantly   reduces   the   incidence   of   all   deep   vein   thrombosis, 
proximal  deep vein thrombosis and all  pulmonary emboli   including fatal  pulmonary 
emboli   (Collings   R   et   al   1988)   (10).   The   International  Multicentre   trial   (32)   also 
established   the   effectiveness   of   low   dose   heparin   for   preventing   fatal   pulmonary 
embolism, a clinically and significantly striking reduction from 0.7% to 0.0%.
ADJUSTED DOSE HEPARIN
The   use   of   adjusted   dose   subcutaneous   heparin   has   been   effective   for 












Prandoni  P et  al   (1996)   (50)   reported  that  LMWH at  doses   twice  as high as  those 




For prophylaxis oral  anticoagulants  can be commenced preoperatively  at   the 
time of surgery, or in the early postoperative period. Oral anticoagulants begun at the 
time of   surgery  or   in   the  early  postoperative  period  may not  prevent  small  venous 
thrombi from forming during or soon after surgery, because the antithrombolic effect is 
not achieved until the third or fourth postoperative day. However they are effective in 










moderate risk general surgical  patients (Robert  VC et al  1972) (52) and in patients 
undergoing neurosurgery (Skillman JJ et al 1978) (57). This is virtually free of clinically 
important side effects.  These  devices  should be used  for  the entire  period until   the 


























The   accepted   anticoagulant   therapy   for   venous   thromboembolism   is   a 
combination   of   continuous   intravenous   heparin   therapy   and   oral   warfarin.   The 




1.5   times   the   control.   Data   from   these   trials   indicate   that   failure   to   achieve   the 
27







Prandoni   P.   et   al   (1992)   (50)   compared   subcutaneous   unmonitored   LMW 










Heparin   induced   thrombocytopenia,   usually   occurs   in   1%  to   2% of   patients 
within 5 to 10 days (Kelton JG 1986) (36).  50% fall  in platelet count occurs,  due to 





























Bleeding during well  controlled oral  anticoagulant therapy  is  usually due  to 
trauma or local lesions such as peptic ulcer. Spontaneous bleeding can occur if excessive 
dosage  of  warfarin   is  given.  Coumarin   induced   skin  necrosis   is   a   rare   but   serious 
complication that requires immediate cessation of oral anticoagulant therapy (Beeker 
CG 1987) (4). It usually occurs between 3 and 10 days after therapy, is commoner in 
women   and   most   often   involves   areas   of   abundant   subcutaneous   tissue   such   as 
abdomen, buttock, thighs and breast.
VENOUS THROMBECTOMY




To  avoid   perioperative  pulmonary   embolism,  we  must  have     a   preoperative 
venogram   to   exclude   thrombus   extension   into   inferior   vena   cava   and   using 
intraoperative PEEP.
In  Sweden  Plate  G   et   al   (1985)   (48)   in   a   randomized   study,   found  positive 
perfusion scans in 45% of all patients on admission with additional defects seen after 1 
and  4  weeks  in  11% and 12% of   conservatively   treated  group and 20% and 0%  in 















The   standard   regimen   of   systemic  anticoagulation  with  heparin   followed  by 
coumadin therapy does not promote lysis to reduce the thrombus load nor does it restore 


















Nasbeth DC et  al   (1965)   (44)   found mortality  rates  after   inferior  vena cava 
ligation to be 19% and leg edema   40%, varicose vein 20% stasis pigmentation (18%) 
venous   claudication   14%   and  ulceration   6%.  Hence  Diccone  VA   et   al   (1970)     (46) 
suggested plication of inferior vena cava  instead of ligation.
IVC FILTERS


















embolism and a  frequency of  0.8% recurrent  fatal  pulmonary embolism. Comparing 



































10 - 20 21 – 30 31 – 40 41 – 50 51 – 60 61 – 70 71 – 80 > 80
Age
AGE INCIDFENCE










Age Male Female Total
10 – 20 ­ 4 4
21 – 30 8 29 37
31 – 40 6 9 15
41 – 50 14 16 30
51 – 60 9 11 20
61 – 70 3 6 9
71 – 80 1 2 3




































Iliofemoral deep vein thrombosis
Femoropopliteal deep vein thrombosis
Popliteal vein thrombosis




























































This     excludes   the   post   caesarean   section   patients.   Patients   who   undergo 
prolonged surgical procedures are at risk of developing venous thromboembolism. The 








































care   treatment   developed   deep   vein   thrombosis   (9%).   This   compares   well   with 
international data. The importance of thromboembolic disease arising in the medical 
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2   had   elevated   antiphospholipid   IgG   antibodies   and   one   patient   had   hyper 
homocysteinemia. Interestingly the last patient, a 29 year old male also suffered from 
severe coronary artery  disease.
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Embolism : Yes  No
Previous DVT :












within previous 2 months : Yes No
Major surgery within 
past 2 months : Yes No
Major trauma / fracture 
within past 2 months : Yes No













ANATOMY OF LOWER LIMB VEINS
PATHOLOGY OF DVT 
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x No DOA Site Predisposing
1 Yasodammal 45 F 668910 05.07.04 (L) IFDVT Idiopathic
2. Rahman 56 M 669772 09.07.04 (L) IFDVT Idiopathic
3. Poongavanam 50 F 669761 09.07.04 (L) IFDVT Ca cervix  
4. Nagammal 30 F 669869 09.07.04 (L) IFDVT Idiopathic
5. Chari 50 M 670333 12.07.04 (L) IFDVT Idiopathic
6. Panchanathan 38 M 671141 16.07.04 BIL IFDVT Idiopathic
7. Kanagambaran 41 F 672856 26.07.04 (L) IFDVT Post OP
8. Banumathi 22 F 672890 26.07.04 (L) IFDVT Post LSCS
9. Lakshmi 25 F 673601 30.07.04 (L) FPDVT Post partum
10. Kanniyammal 53 F 666081 20.07.04 (L) IFDVT Trauma
11. Hamsa 25 F 171821 16.07.04 (L) IFDVT Post LSCS
12.  Thilagam 19 F 674875 06.08.04 (L) IFDVT Post LSCS
13. Gnanamani 70 F 675303 09.08.04 (L) IFDVT Idiopathic
14. Peeramana 50 F 675306 09.08.04 BIL IFDVT Ca. Pancreas
15. Muniamma 48 F 675347 09.08.04 (L) IFDVT Idiopathic
16. Geetha 40 F 675402 01.08.04 (R) FPDVT Post OP
17. Malla 45 F 673850 02.08.04 (R) IFDVT Trauma
18. Savithiri 41 F 676368 15.08.04 (R) IFDVT Idiopathic
19. Lakshmiammal 50 F 678490 26.08.04 (L) IFDVT Idiopathic
20. Moses 45  M 678904 19.08.04 (R) POP DVT Trauma
21. Hameed 50 M 678453 24.08.04 (R) IFDVT Cannula
22. Radhi 25 F 679574 02.09.04 (L) IFDVT Post LSCS
23. Jeyalaxmi 46 F 680318 06.09.04 (L) IFDVT POST OP
24. Lakshmi 55 F 678835 20.08.04 (L) FPDVT Trauma
25. Pavalakodi 55 F 679876 20.08.04 (L) IFDVT Trauma
26. Ayyadurai 40 M 680941 01.09.04 (L) SCDVT Acute Med. Cond.
27. Sonabee 65 F 680104 01.09.04 (L) FPDVT Trauma
28. Satamthala 63 F 680987 09.09.04 (L) IFDVT Idiopathic
29. Pachaiyappan 49 F 681560 13.09.04 (L) IFDVT Idiopathic




x No DOA Site Predisposing
31. Thangavel 56 M 683530 24.09.04 (R) IFDVT Idiopathic
32. Malarkodi 22 F 683732 27.09.04 BIL IFDVT Pregnancy
33. Natraj 41 M 684568 30.09.04 (L) IFDVT Post OP
34. Perumal 65 M 685096 04.10.04 (R) FPDVT Acute Med. Cond.
35. Rena 44 F 685782 07.10.04 (L) IFDVT Idiopathic
36. Alamelu 47 F 685740 07.10.04 (L) IFDVT Post OP
37. Sasikala 21 F 685851 10.10.04 (L) IFDVT Post partum
38. Amuda 50 F 685536 05.10.04 (L) IFDVT Acute Med. Cond.
39. Nallayi 57 F 685018 01.10.04 (R) IFDVT Cannula
40. Shankar 35 M 685103 01.10.04 (L) IFDVT Acute Med.Cond.
41. Jayagandhi 24 F 687731 18.10.04 (L) IFDVT Post partum
42. Chandra 50 F 687440 16.10.04 (L) IFDVT Ca.Stomach
43. Umabanu 26 F 689403 28.10.04 (L) IFDVT Idiopathic
44. Anusuya 55 F 689467 29.10.04 (L) IFDVT Post OP
45. Ellammal 57 F 691779 13.10.04 (L) IFDVT Ca Cervix
46. Subramani 47 M 689753 19.11.04 (R) POP DVT Cannula
47. Chitra 25 F 690132 22.11.04 (L) FPDVT Trauma
48. Gandhimathi 26 F 694963 30.11.04 (L) IFDVT Pregnancy
49. Perumal 55 M 690741 05.11.04 (L) IFDVT Idiopathic
50. Badrunnisha 85 M 695803 11.12.04 (L) IFDVT Idiopathic
51. Jayalakshmi 50 F 689885 19.12.04 (L) IFDVT Ca breast
52. Vijayalakhsmi 35 F 689710 10.12.04 BIL IFDVT Ca rectum
53. Saraswathy 64 F 689690 03.12.04 (L) IFDVT Acute Med. Cond.
54. Kumar 43 M 700053 27.12.04 (L) POPDVT Idiopathic
55. Ahamed Rasheed 21 M 698632 21.12.04 (R) IFDVT Idiopathic
56. Ramanya 45 M 697814 16.12.04 (R) IFDVT Idiopathic
57. Krishnan 64 M 700478 30.12.04 (L) FPDVT Idiopathic
58. Kuppammal 73 F 701560 06.01.05 (L) IFDVT Trauma
59. Mohan 50 M 701440 05.01.05 (L) POPDVT Trauma




x No DOA Site Predisposing
61. Mariya Stephen 54 M 702809 29.01.05 (L) IFDVT Trauma
62. Selvaraj 55 M 706997 07.02.05 (L) IFDVT Idiopathic
63. Thilagavathy 27 F 707523 10.02.05 (L) IFDVT Idiopathic
64. Nirmala 37 F 707624 11.02.05 (L) IFDVT Pregnancy
65. Pushpa 30 F 707671 11.02.05 (R) IFDVT Post partum
66. Subramani 22 M 706579 06.02.05 (L) POPDVT Trauma
67. Govindammal 52 F 700259 06.02.05 (R) FPDVT Cannula
68. Ashya Parveen 22 F 711778 01.03.05 (L) IFDVT Post LSCS
69. Kumari 15 F 712748 07.03.05 (L) FPDVT Idiopathic
70. Mani 50 M 713379 10.03.05 (R) IFDVT Idiopathic
71. Rohini 55 F 713048 10.03.05 (R) IFDVT Idiopathic
72. Kumar 69 M 834105 10.03.05 (R) IFDVT Trauma
73. Abdul Saleem 45 M 697838 11.03.05 (L) IFDVT Post OP
74. Krishnaveni 45 F 661972 25.03.05 (L) IFDVT Post OP
75. Nirmala 25 F 714057 15.03.05 (L) IFDVT Post partum
76. Lourdemary 35 F 715322 21.03.05 (L) IFDVT Acute Med. Cond.
77. Yasoda 65 F 716292 27.03.05 (L) IFDVT Post OP
78. Sandya 24 F 717132 31.03.05 (L) IFDVT Idiopathic
79. Thangavel 50 M 717635 31.03.05 (R) IFDVT Idiopathic
80. Gopi 55 M 720067 18.04.05 (L) IFDVT Idiopathic
81. Probudoss 28 M 720097 18.04.05 (L) IFDVT Idiopathic
82. Chinnadurai 50 M 714311 02.04.05 (L) IFDVT Trauma
83. Indra 50 F 720118 04.04.05 (R) FPDVT Idiopathic
84. Elizabeth 48 F 721018 23.04.05 (L) IFDVT Idiopathic
85. Pushpavathy 75 F 720748 19.04.05 (R) IFDVT Ca Cervix
86. Padmavathy 36 F 722042 28.04.05 (L) IFDVT Post OP
87. Nirmala 24 F 721582 26.04.05 (L) IFDVT Post LSCS
88. Kasthuri 37 F 724010 09.05.05 (L) IFDVT Idiopathic
89. Mahalingam 44 M 726216 16.05.05 (L) IFDVT  Post OP
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91. Saroja 58 F 727643 23.05.05 (R) IFDVT Ca Cervix
92. Ramani 27 F 727699 24.05.05 (L) IFDVT Idiopathic
93. Thangavel 40 M 727907 26.05.05 (L) IFDVT Acute Med.Cond.
94. Chandrasekar 28 M 715276 29.05.05 (L) POPDVT Ca Rectum
95. Rajammal 60 F 729286 31.05.05 (L) IFDVT Idiopathic
96. Revathy 10 F 717835 17.05.01 (L) IFDVT Acute Med. Cond.
97. Angammal 72 F 721636 10.05.05 (L) IFDVT Trauma
98. Bebya 25 F 726618 19.05.05 (R) IFDVT Acute Med. Cond.
99. Giri 30 M 729659 02.06.05 (L) AXIDVT Idiopathic
100. Babu 40 M 730936 14.06.05 (L) IFDVT Renal Cell Ca
101. Sanmyammal 45 F 729496 20.06.05 (L) IFDVT Trauma
102. Balasundaran 45 F 729496 20.06.05 (L) IFDVT Trauma
103. Venkatesh 23 M 734342 29.06.05 (L) POPDVT Post OP
104. Jecintha 22 F 731005 09.06.05 (L) IFDVT Post OP
105. Pitchai Mohd 53 M 735089 30.06.05 (R) IFDVT Idiopathic
106. Anjalai 27 F 739371 19.07.05 (L) IFDVT Idiopathic
107. Radabai 55 F 735593 13.07.05 (L) IFDVT Trauma
108. Mallika 40 F 736010 05.07.05 (L) IFDVT Ca Rectum
109. Varalakshmi 22 F 738402 14.07.05 BIL.IFDVT Post partum
110. Kotteswaran 34 M 736635 19.07.05 (L) IFDVT Trauma
111. Ruckmani 65 F 737614 13.07.05 (R) FPDVT Cannula
112. Balakrishnan 54 M 734098 19.07.05 (R) FPDVT Ca bladder
113. Malar 17 F 811005  08.07.05 (L) IFDVT Post OP
114. Kala 24 F 738200 14.07.05 (L) IFDVT Idiopathic
115. Soundari 25 F 739684 22.07.05 (L) IFDVT Post partum
116. Ramalingam 30 M 739772 21.07.05 (L) IFDVT Idiopathic
117. Kasthrui 24 F 736579 01.07.05 (L) IFDVT Post partum
118. Kavitha 25 F 741305 28.07.05 (L) IFDVT Idiopathic
119. Sivagami 37 F 740997 27.07.05 (L) IFDVT Idiopathic
IFDVT ­ Iliofemoral DVT
FPDVT ­ Femoropopliteal DVT
POPDVT ­ Popliteal DVT
AXIDVT ­ Axillary DVT
SCDVT ­ Subclavian DVT
